Phase II: Adaptive De-escalation of Radiation Therapy Dose In Favorable Risk HPV-Positive Oropharyngeal Carcinoma (ART)

Brief description of study

The main goal of this study is to determine if deescalating chemoradiation treatment based on early tumor shrinkage at mid-treatment can result in similar cancer cure rates as standard treatment but fewer side effects and better quality of life.


Clinical Study Identifier: s17-00330
ClinicalTrials.gov Identifier: NCT03215719
Principal Investigator: Kenneth S Hu
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.